Innovative Cardiovascular Solutions said today that it closed an $8 million Series C round of financing to support clinical trials of its Emblok embolic protection system as well as manufacturing and operational activities. The Kalamazoo, Mich.-based company’s Emblok system is an embolic protection device designed for full circumferential aortic collection while protecting the cerebral, abdominal […]
Innovative Cardiovascular Solutions
Innovative Cardiovascular Solutions raises $5m in oversubscribed Series B
Innovative Cardiovascular Solutions said today it raised $5 million in an oversubscribed Series B round of financing to support its Emblok embolic protection system. The Emblok system is an embolic protection device designed for full circumferential aortic collection while protecting the cerebral, abdominal and peripheral vasculature from embolic debris. The system is designed for use […]
Innovative Cardiovascular Solutions raises $3m
Innovative Cardiovascular Solutions raised $3.1 million in a new round of equity financing, according to an SEC filing posted this week. The Kalamazoo, Mich.-based company is developing the Emblok system, an embolic protection device designed for full circumferential aortic collection while protecting the cerebral, abdominal and peripheral vasculature from embolic debris. The system includes an […]
7 medtech stories we missed this week: March 17, 2017
The FDA awarded 510(k) clearance to a couple of medtech companies this week while others received tax breaks and incentives, including a local tax break for a $154 million Stryker R&D facility planned in Michigan. Here are 7 medtech stories we missed this week but thought were worth mentioning. 1. FirstRay wins FDA 510(k) clearance […]
